Literature DB >> 32134862

Longxuetongluo capsule alleviates lipopolysaccharide-induced neuroinflammation by regulating multiple signaling pathways in BV2 microglia cells.

Qian Hong1, Yang Yang, Zenghui Wang, Liuliu Xu, Zhao Yan.   

Abstract

BACKGROUND: Longxuetongluo capsule (LTC), derived from the total phenolic compounds of Chinese dragon's blood, is now used in the treatment of ischemic stroke in convalescence. The aim of this study is to explore the neuroprotective effect of LTC from the perspective of neuroinflammation.
METHODS: Cell viability and lactate dehydrogenase (LDH) release were measured by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) and LDH assay kit. Proinflammatory mediators and cytokines production including Nitric Oxide (NO), prostaglandin E2, (PGE2), interleukin (IL-β), IL-6, and tumor necrosis factor-α (TNF-α) were detected by enzyme-linked immunosorbent assay (ELISA) assay. In addition, western blot was used to detect the expression of inflammatory proteins associated with the mitogen-activated protein kinases (MAPKs), janus kinase/signal transducer and activator of tranions (JAK/STAT), nuclear transcription factor κB (NF-κB), and nuclear factor erythroid-2-related actor 2/heme oxygenase 1 (Nrf2/HO-1) signaling pathways. Moreover, immunofluorescence assay and electrophoretic mobility shift assays (EMSA) were performed to determine the Nrf2 translocation and the binding-DNA activity of NF-κB, respectively.
RESULTS: LTC at 0.5 to 2 μg/mL significantly increased cell viability and decreased LDH, NO, PGE2, IL-1β, IL-6, and TNF-α production in oxygen-glucose deprivation/reoxygenation (OGD/R) and lipopolysaccharide (LPS)-induced BV2 microglia cells. Meanwhile, LTC not only decreased the protein expressions of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2) but also down-regulated phosphorylation of extracellular signal-regulated kinase (ERK)1/2, p38, and up-regulated HO-1 expression via nuclear translocation of Nrf2. LTC can significantly inhibit the phosphorylation of JAK1/STAT3 and reduce the translocation of NF-κB from cytosol to nucleus as well as the binding-DNA activity. PC12 cell pretreated with LTC-condition medium (CM) significantly alleviated LPS-induced neurotoxicity and increased PC12 cell viability in a dose-dependent manner.
CONCLUSION: The present study showed that LTC exhibited a strong antineuroinflammatory activity and neuroprotective effects on LPS-stimulated BV2 microglial cells and PC12 cells.

Entities:  

Year:  2020        PMID: 32134862     DOI: 10.1097/JCMA.0000000000000258

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  5 in total

1.  Detecting Key Functional Components Group and Speculating the Potential Mechanism of Xiao-Xu-Ming Decoction in Treating Stroke.

Authors:  Yu-Peng Chen; Ke-Xin Wang; Jie-Qi Cai; Yi Li; Hai-Lang Yu; Qi Wu; Wei Meng; Han-Duo Wang; Chuan-Hui Yin; Jie Wu; Mian-Bo Huang; Rong Li; Dao-Gang Guan
Journal:  Front Cell Dev Biol       Date:  2022-05-12

2.  Inhibition of Long Noncoding RNA SNHG15 Ameliorates Hypoxia/Ischemia-Induced Neuronal Damage by Regulating miR-302a-3p/STAT1/NF-κB Axis.

Authors:  Chunting Hu; Chen Li; Qiaoya Ma; Ruili Wang; Ya He; Hui Wang; Guogang Luo
Journal:  Yonsei Med J       Date:  2021-04       Impact factor: 3.052

Review 3.  Activation of Nrf2 by Natural Bioactive Compounds: A Promising Approach for Stroke?

Authors:  Agnese Gugliandolo; Placido Bramanti; Emanuela Mazzon
Journal:  Int J Mol Sci       Date:  2020-07-10       Impact factor: 5.923

4.  Forsythoside B attenuates memory impairment and neuroinflammation via inhibition on NF-κB signaling in Alzheimer's disease.

Authors:  Fan'ge Kong; Xue Jiang; Ruochen Wang; Siyu Zhai; Yizhi Zhang; Di Wang
Journal:  J Neuroinflammation       Date:  2020-10-15       Impact factor: 8.322

5.  Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms.

Authors:  Bo Pan; Jing Sun; Ziyu Liu; Lingxiao Wang; Huixia Huo; Yunfang Zhao; Pengfei Tu; Wei Xiao; Jiao Zheng; Jun Li
Journal:  J Adv Res       Date:  2021-02-09       Impact factor: 10.479

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.